STATEWIDE CANCER DATA SHARED RESOURCE Statewide Cancer Data (SCD) is a two component SR that combines Rapid Case Ascertainment (RCA) and the Cancer Information and Population Health Resource (CIPHR). This resource reflects a commitment of the cancer center and of the CPC, CR, BC and CE Programs to support research in real-world populations with a focus on disparities and access to care ? particularly in the state of North Carolina. A strong relationship between RCA and the North Carolina Central Cancer Registry (CCR), and the hospital tumor registrars allows RCA to facilitate population-based studies of cancer for Lineberger Cancer Center and outside investigators. For rapid case ascertainment, the Central Cancer Registry utilizes RCA personnel, and proactively requests and obtains diagnostic information within one month of the patient?s diagnosis. The other component of this resource is CIPHR, which includes cancer case data from CCR linked to healthcare administrative claims data from Medicare, Medicaid, and private insurance. The resulting claims dataset represents over 8 million individuals. Beneficiaries are reconciled across payers and linked to approximately 750,000 North Carolina cancer cases from the last decade. The size and complexity of the population-based datasets created and housed by this resource require an interdisciplinary staff to successfully and efficiently manage, analyze, and understand the data. SR staff apply diverse and innovative data management and analytic methods many specifically created for CIPHR to answer important population-based questions about the LCCC catchment area. Linkage of LCCC population-based cohorts has been accomplished. Researcher support from SCD typically extends from development of the initial research question, gathering preliminary data for grant applications through cohort discovery, statistical analysis, and manuscript writing. In FY2019, 37 LCCC members representing 93% of users used the SCD SR. This is a cost-effective mechanism to both collect cancer cases efficiently across the state and to disseminate that information. Since CIPHR began linking to Medicare data in 2012, it has been extensively used by faculty, trainees, and various collaborators both within UNC and at other cancer centers. To date, more than $15M in external funding has been enabled by this shared resource. The SCD requests $206,586 from the CCSG, which is 12% of the total FY20 $1.8 M operating budget, $900,000 of which is provided by the LCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089836
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Spencer, Jennifer C; Brewer, Noel T; Trogdon, Justin G et al. (2018) Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients. Am J Public Health 108:946-950
Hu, Jiemiao; Sun, Chuang; Bernatchez, Chantale et al. (2018) T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors. Clin Cancer Res 24:2920-2934
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Bailey, Rachel M; Armao, Diane; Nagabhushan Kalburgi, Sahana et al. (2018) Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy. Mol Ther Methods Clin Dev 9:160-171
Liu, E; Tong, Y; Dotti, G et al. (2018) Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. Leukemia 32:520-531
Chao, Yvonne L; Pecot, Chad V (2018) Immunotherapy combinations emerging in non-small-cell lung cancer. Immunotherapy 10:627-629
Braithwaite, Dejana; Miglioretti, Diana L; Zhu, Weiwei et al. (2018) Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Intern Med 178:494-501
Dusetzina, Stacie B; Huskamp, Haiden A; Winn, Aaron N et al. (2018) Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws. JAMA Oncol 4:e173598
Smith, Collin-Jamal; Allard, Denise E; Wang, Yan et al. (2018) IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration. J Immunol 200:1580-1592
Montgomery, Nathan D; Tomoka, Tamiwe; Krysiak, Robert et al. (2018) Practical Successes in Telepathology Experiences in Africa. Clin Lab Med 38:141-150

Showing the most recent 10 out of 1525 publications